Dermatology Doctors in Orland Park, IL Accepting Medicare

8 Dermatology doctors found. Showing 1 - 8

Vanessa Jo Waldvogel, Dermatology - MOHS-Micrographic Surgery Medicare: Medicare Enrolled Practice Location: 9131 W 151st St, Orland Park, IL 60462 Phone: 708-323-3376

Dr. John T Keane, M.D. Dermatology - Dermatopathology Medicare: Medicare Enrolled Practice Location: 16105 S La Grange Rd, Orland Park, IL 60467 Phone: 708-636-3767    Fax: 708-636-4361

Dr. Ally-khan B Somani, M.D., PH.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 16105 S La Grange Rd, Orland Park, IL 60467 Phone: 708-636-3767    Fax: 708-873-5849

Christine Kay Sickles, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 16105 S La Grange Rd, Orland Park, IL 60467 Phone: 708-636-3767    Fax: 708-636-4361

Dr. Kenneth B Bielinski, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 16105 S La Grange Rd, Orland Park, IL 60467 Phone: 708-636-3767    Fax: 708-636-4361

Artem Sergeyenko, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 16105 S La Grange Rd, Orland Park, IL 60467 Phone: 708-636-3757    Fax: 708-636-4361

Dr. Cheuk W Yung, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 15300 West Ave, Suite 120 South, Orland Park, IL 60462 Phone: 708-460-7890    Fax: 708-460-7842

Dr. Shirley Jean-baptiste, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 15300 West Ave, Suite 120 South, Orland Park, IL 60462 Phone: 708-460-7890    Fax: 708-460-5537

News Archive

Infertility centers under scrutiny

Private infertility treatment centers in Britain are set to come under increased scrutiny. These centers have come under scrutiny for exploiting vulnerable couples with their high fees and exaggerated success story claims.

FDA clears Xpert EV test for meningitis

The U.S. Food and Drug Administration (FDA) has cleared for marketing a test that uses molecular biology to quickly detect the presence of viral meningitis.

Progress update on Johnson & Johnson and Crucell's public offer

Pursuant to the provisions of Section 7 paragraph 1(a) of the Dutch Decree on Public Takeover Bids (Besluit Openbare Biedingen Wft) requiring a public announcement within four weeks following the announcement of an intended public offer to provide a status update, Johnson & Johnson (NYSE: JNJ) and Crucell N.V. provide the following joint update.

Perrigo files ANDA for butoconazole nitrate vaginal cream

Perrigo Company announced that it has filed with the U.S. Food and Drug Administration an Abbreviated New Drug Application for butoconazole nitrate vaginal cream, 2% and that is has notified KV Pharmaceutical Company, the owner of the New Drug Application as well as FemmePharma, the listed owner of the patent, of its ANDA filing. KV is a licensee under the patent. Perrigo believes it is first-to-file on this product.

Read more Medical News

› Verified 4 days ago